is semaglutide off the fda shortage list US judge upholds FDA's removal of Ozempic, Wegovy from drug FDA declares end to Ozempic

Phase 3 trials (ATTAIN-1, ATTAIN-2, ACHIEVE series) demonstrated approximately 12% weight loss and robust glycemic control, with an NDA submitted to the FDA under the Commissioners National Priority Voucher program ( If approved, orforglipron would represent direct competition to oral semaglutide, potentially at lower cost and with superior convenience

When you take semaglutide, it starts working on those GLP-1 receptors

Aroda, Julio Rosenstock, Yasuo Terauchi, Yuksel Altuntas, Nebojsa M

It is one of the most significant threats to your long-term health, and it is where tirzepatide may offer its most meaningful benefits beyond weight loss